GENE ENCODING OXALATE DECARBOXYLASE FROM ASPERGILLUS PHOENICES

Abstract: A novel nucleic acid sequence encoding Aspergillus phoenices oxalate decarboxylase (APOXD) has been determined, as well as the encoded amino acid sequence. The gene and its encoded protein are useful in degrading oxalate, in diagnostic assays of oxalate, and as a selectable marker.

Description: GENE ENCODING OXALATE DECARBOXYLASE FROM ASPERGILLUS PHOENICES Field of the Invention This invention relates to a novel nucleic acid sequence encoding oxalate decarboylyase isolated from Aspergillus phoenices and to use of the nucleic acid sequence to produce its encoded protein. Background of the Invention Oxalic acid (oxalate) is a difϊusable toxin associated with various plant diseases, particularly those caused by fungi. Some leafy green vegetables, including spinach and rhubarb, produce oxalate as a nutritional stress factor. When plants containing oxalate are consumed in large amounts, they can be toxic to humans. Oxalate is used by pathogens to gain access into and subsequently throughout an infected plant. See for example, Mehta and Datta, The Journal of Biological Chemistry, 266:23548-23553, 1991; and published PCT Application WO92/14824. Field crops such as sunflower, bean, canola, alfalfa, soybean, flax, safflower, peanut, clover, as well as numerous vegetable crops, flowers, and trees are susceptible to oxalate-secreting pathogens. For example, fungal species including Sclerotinia and Sclerotium use oxalic acid to provide an opportunistic route of entry into plants, causing serious damage to crops such as sunflower. Because of the role of oxalate in plant disease and toxicity, compounds that inhibit oxalate mediated disease, and particularly genes encoding such inhibitory degrading molecules, are greatly needed. Enzymes that utilize oxalate as a substrate have been identified. These include oxalate oxidase and oxalate decarboxylase. Oxalate oxidase catalyzes the conversion of oxalate to CO 2 and H 2 O 2 . A gene encoding barley oxalate oxidase has been cloned from a barley root cDNA library and sequenced (See PCT publication No. WO92/ 14824). A gene encoding wheat oxalate oxidase activity (Germin) has been isolated and sequenced, (PCT publication No. WO 94/13790) and the gene has been introduced into a canola variety. Canola plants harboring the gene appeared to show some resistance to Sclerotinia sclerotiorum, in vitro (Dumas, et al., 1994, Abstracts: 4th hit 7. Congress of Plant Molecular Biology, #1906). Oxalate decarboxylase converts oxalate to CO and formic acid. A gene encoding oxalate decarboxylase has been isolated from Collybia velutipes (now termed Flammulina velutipes) and the cDNA clone has been sequenced (WO94/ 12622, published 9 June 1994). Oxalate decarboxylase activities have also been described in Aspergillus niger and Aspergillus phoenices (Emiliani et al., 1964, ARCH. Biochem. Biophys. 105:488-493), however the amino acid sequence and nucleic acid sequence encoding these enzyme activities have not been isolated or characterized. Enzymatic assays for clinical analysis of urinary oxalate provide significant advantages in sensitivity and qualification Obzansky, et al., 1983, Clinical Chem. 29:1815- 1819. For many reasons, including reactivity with interfering analytes and the high cost of available oxalate oxidase used in this diagnostic assay, alternative enzymes are needed. (Lathika et al., 1995, Analytical Letters 28: 425-442). In this application, we disclose the isolation, cloning, and sequencing of a unique gene encoding an oxalate decarboxylase enzyme from Aspergillus phoenices. The gene is useful in producing highly purified Aspergillus phoenices oxalate decarboxylase enzyme, in producing transgenic plant cells and plants expressing the enzyme in vivo, and in diagnostic assays of oxalate. Summary of the Invention The present invention provides a nucleic acid sequence encoding oxalate decarboxylase isolated from Aspergillus phoenices (APOXD). The gene sequence [Seq ID No:l], the recombinant protein produced therefrom [Seq ID No:2], and vectors, transformed cells, and plants containing the gene sequence are provided as individual embodiments of the invention, as well as methods using the gene or its encoded protein. The nucleic acid is useful for producing oxalate decarboxylase for commercial applications, including degradation of oxalic acid, protection against oxalic acid toxicity, and diagnostic assays to quantify oxalate. The nucleic acid of the invention is also useful as a selectable marker. Growth of plant cells in the presence of oxalic acid favors survival of plant cells transformed with the coding sequence of the gene. The present invention also includes compositions and methods for degrading oxalic acid, in providing protection against oxalic acid toxicity, and in combating and providing protection against plant pathogens that utilize oxalate to gain access to plant tissue or otherwise in the course of the pathogenesis of the disease. Oxalate decarboxylase from Aspergillis phoenices (APOXD) of the present invention is combined with an appropriate carrier for delivery to the soil or plants. Alternatively, plant cells are transformed with the nucleic acid sequence of the invention for expression of APOXD in vivo. Brief Description of the Drawings Figure 1 is a diagram showing a first primer strategy for amplification of a portion of the nucleic acid sequence encoding APOXD. Figure 2 is a diagram showing the primer position and design of nested, gene-specific primers (arrows above diagram) for 3' RACE and the single gene specific primer (arrow beneath diagram) used for 5' RACE. Figure 3 is a diagram showing the construction of plasmid pPHP9723 containing the 1.4kb nucleic acid sequence encoding APOXD including leader and pre- sequence. Figure 4 is a diagram of the plasmid pPF£P9723. Figure 5 is a diagram showing the plasmid pPHP9762 containing the nucleic acid sequence encoding APOXD with the fiingal leader and pre-sequence replaced by the plant signal sequence of the wheat oxalate oxidase gene, Germin. Detailed Description of the Invention The purified oxalate decarboxylase of the present invention has many commercial uses, including inhibiting oxalate toxicity of plants and preventing pathogenic disease in plants where oxalic acid plays a critical role. It has been suggested that degradation of oxalic acid is a preventative measure, e.g., to prevent invasion of a pathogen into a plant, or during pathogenesis, when oxalic acid concentrations rise (Dumas, et al., 1994, Supra). The gene of the invention is also useful as a selectable marker of transformed cells, for diagnostic assay of oxalate, and for production of the enzyme in plants. Nucleic Acid Sequence Encoding APOXD A nucleic acid sequence encoding APOXD [Seq. ID No: 1] has now been determined by methods described more fully in the Examples below. Briefly, DNA encoding APOXD was obtained by amplification of genomic A. phoenices DNA using a RACE strategy as described in Innis et. al., eds., 1990, PCR Protocols. A Guide to Methods and Applications, Academic Press, San Diego, CA, pages 28-38. See also pages 39-45, "Degenerate primers". The nucleic acid sequence and its deduced amino acid sequence [Seq. ID No:2] are shown below in Table 1. The predicted signal peptide [Seq. ID No: 3] and pre-protein [Seq. ID No: 4] are shown along with the potential cleavage site between them as determined by computer analysis using PC gene software (IntelliGenetics, Inc., Mountain View, CA). The mature protein [Seq. ID No: 5] is also indicated. This 1.4 kb sequence encodes a 458 amino acid enzyme subunit with a calculated molecular weight of 51,994 daltons. Southern hybridization indicates that the enzyme is encoded by a single gene in the Aspergillis phoenices genome. The plasmid pPHP9685 containing the nucleic acid sequence encoding APOXD as an insert was deposited with the A.T.C.C. on , 1997, having Accession No. . TABLE 1 SEQUENCE OF FULL LENGTH APOXD DNA ΪSignal PeptideC GGCTTGTCAG 3ATCCTTCCA AAG lATG CAG CTA ACC CTG CCA CCA CGT CAG CTG 53 iMet Gin Leu Thr Leu Pro Pro Arg Gin Leu 1 1 5 10 TTG CTG AGT TTC GCG ACC GTG GCC GCC CTC CTT GAT CCA AGC CAT GGA 101 Leu Leu Ser Phe Ala Thr Val Ala Ala Leu Leu Asp Pro Ser His Gly 15 20 25 IPre- -protein® IGGC CCG GTC CCT AAC GAA GCG TAC CAG CAA CTA CTG CAG ATT CCC GCC 149 iGly Pro Val Pro Asn Glu Ala Tyr Gin Gin Leu Leu Gin He Pro Ala 130 35 40 .Mature Protein® TCA TCC CCA TCC ATT TTC TTC ICAA GAC AAG CCA TTC ACC CCC GAT CAT 197 Ser Ser Pro Ser He Phe Phe IGln Asp Lys Pro Phe Thr Pro Asp His 45 150 55 Nr l CGC GAC CCC TAT GAT CAC AAG GTG GAT GCG ATC GGG GAA GGC CAT GAG 245 Arg Asp Pro Tyr Asp His Lys Val Asp Ala He Gly Glu Gly His Glu 60 65 70 CCC TTG CCC TGG CGC ATG GGA GAT GGA GCC ACC ATC ATG GGA CCC CGC 293 Pro Leu Pro Trp Arg Met Gly Asp Gly Ala Thr He Met Gly Pro Arg 75 80 85 90 AAC AAG GAC CGT GAG CGC CAG AAC CCC GAC ATG CTC CGT CCT CCG AGC 341 Asn Lys Asp Arg Glu Arg Gin Asn Pro Asp Met Leu Arg Pro Pro Ser 95 100 105 ACC GAC CAT GGC AAC ATG CCG AAC ATG CGG TGG AGC TTT GCT GAC TCC 389 Thr Asp His Gly Asn Met Pro Asn Met Arg Trp Ser Phe Ala Asp Ser 110 115 120 CAC ATT CGC ATC GAG GAG GGC GGC TGG ACA CGC CAG ACT ACC GTA CGC 437 His He Arg He Glu Glu Gly Gly Trp Thr Arg Gin Thr Thr Val Arg 125 130 135 GAG CTG CCA ACG AGC AAG GAG CTT GCG GGT GTA AAC ATG CGC CTC GAT 485 Glu Leu Pro Thr Ser Lys Glu Leu Ala Gly Val Asn Met Arg Leu Asp 140 145 150 GAG GGT GTC ATC CGC GAG TTG CAC TGG CAT CGA GAA GCA GAG TGG GCG 533 Glu Gly Val He Arg Glu Leu His Trp His Arg Glu Ala Glu Trp Ala 155 160 165 170 TAT GTG CTG GCC GGA CGT GTA CGA GTG ACT GGC CTT GAC CTG GAG GGA 581 Tyr Val Leu Ala Gly Arg Val Arg Val Thr Gly Leu Asp Leu Glu Gly 175 180 185 GGC AGC TTC ATC GAC GAC CTA GAA GAG GGT GAC CTC TGG TAC TTC CCA 629 Gly Ser Phe He Asp Asp Leu Glu Glu Gly Asp Leu Trp Tyr Phe Pro 190 195 200 TCG GGC CAT CCC CAT TCG CTT CAG GGT CTC AGT CCT AAT GGC ACC GAG 677 Ser Gly His Pro His Ser Leu Gln Gly Leu Ser Pro Asn Gly Thr Glu 205 210 215 TTC TTA CTG ATC TTC GAC GAT GGA AAC TTT CC GAG GAG TCA ACG TTC 725 Phe Leu Leu He Phe Asp Asp Gly Asn Phe Ser Glu Glu Ser Thr Phe 220 225 230 TTG TTG ACC GAC TGG ATC GCA CAT ACA CCC AAG TCT GTC CTC GCC GGA 773 Leu Leu Thr Asp Trp He Ala His Thr Pro Lys Ser Val Leu Ala Gly 235 240 245 250 AAC TTC CGC ATG CGC CCA CAA ACA TTT AAG AAC ATC CCA CCA TCT GAA 821 Asn Phe Arg Met Arg Pro Gin Thr Phe Lys Asn He Pro Pro Ser Glu 255 260 265 AAG TAC ATC TTC CAG GGC TCT GTC CCA GAC TCT ATT CCC AAA GAG CTC 869 T. c: T . P a ~ n f.1 v Val Pro »r Tl P Pr-o T. _7 T.ou CCC CGC AAC TTC AAA GCA TCC AAG CAG CGC TTC ACG CAT AAG ATG CTC 917 Pro Arg Asn Phe Lys Ala Ser Lys Gin Arg Phe Thr His Lys Met Leu 285 290 295 GCT CAA AAA CCC GAA CAT ACC TCT GGC GGA GAG GTG CGC ATC ACA GAC 965 Ala Gin Lys Pro Glu His Thr Ser Gly Gly Glu Val Arg He Thr Asp 300 305 310 TCG TCC AAC TTT CCC ATC TCC AAG ACG GTC GCG GCC GCC CAC CTG ACC 1013 Ser Ser Asn Phe Pro He Ser Lys Thr Val Ala Ala Ala His Leu Thr 315 320 325 330 ATT AAC CCG GGT GCT ATC CGG GAG ATG CAC TGG CAT CCC AAT GCG GAT 1061 He Asn Pro Gly Ala He Arg Glu Met His Trp His Pro Asn Ala Asp 335 340 345 GAA TGG TCC TAC TTT AAG CGC GGT CGG GCG CGA GTG ACT ATC TTC GCT 1109 Glu Trp Ser Tyr Phe Lys Arg Gly Arg Ala Arg Val Thr He Phe Ala 350 355 360 GCT GAA GGT AAT GCT CGT ACG TTC GAC TAC GTA GCG GGA GAT GTG GGC 1157 Ala Glu Gly Asn Ala Arg Thr Phe Asp Tyr Val Ala Gly Asp Val Gly 365 370 375 ATT GTT CCT CGC AAC ATG GGT CAT TTC ATT GAG AAC CTT AGT GAT GAC 1205 He Val Pro Arg Asn Met Gly His Phe He Glu Asn Leu Ser Asp Asp 380 385 390 GAG AGG TCG AGG TGT TGG AAA TCT TCC GGG CGG ACC GAT TCC GGG ACT 1253 Glu Arg Ser Arg Cys Trp Lys Ser Ser Gly Arg Thr Asp Ser Gly Thr 395 400 405 410 TTT CTT TGT TCC AGT GGA TGG GAG AGA CGC CGC AGC GGA TGG TGG CAG 1301 Phe Leu Cys Ser Ser Gly Trp Glu Arg Arg Arg Ser Gly Trp Trp Gin 415 420 425 AGC ATG TGT TTA AGG ATG ATC CAG ATG CGG CCA GGG AGT TCC TTA AGA 1349 Ser Met Cys Leu Arg Met He Gin Met Arg Pro Gly Ser Ser Leu Arg 430 435 440 GTG TGG AGA GTG GGG AGA AGG ATC CAA TTC GGA GCC CAA GTG AGT AGA 1397 Val Trp Arg Val Gly Arg Arg He Gin Phe Gly Ala Gin Val Ser Arg 445 450 455 IStop ITGA GGTTCTACGC GTGTATTTTG CTGATATCAT CGAAGCC 1437 Redundancy in the genetic code permits variation in the gene sequences shown in Table 1 In particular, one skilled in the art will recognize specific codon preferences by a specific host species and can adapt the disclosed sequence as preferred for the desired host For example, rare codons having a frequency of less than about 20% in known sequence of the desired host are preferably replaced with higher frequency codons. Codon preferences for a specific organism may be calculated, for example, codon usage tables available on the INTERNET at the following address: http://www.dna.affrc.go.jp/~nakamura/codon.html. One specific program available for Arabidopsis is found at: http://genome-www.stanford.edu/Arabidopsis/codon_usage.html. Additional sequence modifications are known to enhance protein expression in a cellular host. These include elimination of sequences encoding spurious polyadenylation signals, exon/intron splice site signals, transposon-like repeats, and other such well-characterized sequences which may be deleterious to gene expression. The G-C content of the sequence may be adjusted to levels average for a given cellular host, as calculated by reference to known genes expressed in the host cell. Where possible, the sequence is modified to avoid predicted hairpin secondary mRNA structures. Other useful modifications include the addition of a translational initiation consensus sequence at the start of the open reading frame, as described in Kozak, 1989, Mol CellBiol. 9:5073-5080. In addition, the native APOXD gene or a modified version of the APOXD gene might be further optimized for expression by omitting the predicted signal and pre- sequence, replacing the signal sequence with another signal sequence, or replacing the signal and pre-sequence with another signal sequence. Any one of the possible APOXD gene variations may work best when combined with a specific promoter and/or termination sequence. APOXD Protein The recombinant APOXD protein produced from the disclosed nucleic acid sequence provides a substantially pure protein useful to degrade oxalate, particularly in applications where highly purified enzymes are required. The recombinant protein may be used in enzymatic assays of oxalate or added to compositions containing oxalate to induce oxalate degradation. When used externally, the enzyme can be placed in a liquid dispersion or solution, or may be mixed with a carrier solid for application as a dust or powder. The particular method of application and carrier used will be determined by the particular plant and pathogen target. Such methods are known, and are described, for example, in U.S. Patent No. 5,488,035 to Rao. Gene Delivery The nucleic acid sequence encoding APOXD may be delivered to plant cells for transient transfections or for incorporation into the plant's genome by methods know in the art. Preferably, the gene is used to stably transform plant cells for expression of the protein in vivo. To accomplish such delivery, the gene containing the coding sequence for APOXD may be attached to regulatory elements needed for the expression of the gene in a particular host cell or system. These regulatory elements include, for example, promoters, terminators, and other elements that permit desired expression of the enzyme in a particular plant host, in a particular tissue or organ of a host such as vascular tissue, root, leaf, or flower, or in response to a particular signal. Promoters A promoter is a DNA sequence that directs the transcription of a structural gene, e.g., that portion of the DNA sequence that is transcribed into messenger RNA (mRNA) and then translated into a sequence of amino acids characteristic of a specific polypeptide. Typically, a promoter is located in the 5' region of a gene, proximal to the transcriptional start site. A promoter may be inducible, increasing the rate of transcription in response to an inducing agent. In contrast, a promoter may be constitutive, whereby the rate of transcription is not regulated by an inducing agent. A promoter may be regulated in a tissue-specific or tissue-preferred manner, such that it is only active in transcribing the operably linked coding region in a specific tissue type or types, such as plant leaves, roots, or meristem. Inducible Promoters An inducible promoter useful in the present invention is operably linked to a nucleotide sequence encoding APOXD. Optionally, the inducible promoter is operably linked to a nucleotide sequence encoding a signal sequence which is operably linked to a nucleotide sequence encoding APOXD. With an inducible promoter, the rate of transcription increases in response to an inducing agent. Any inducible promoter can be used in the present invention to direct transcription of APOXD, including those described in Ward, et al., 1993, Plant Molecular Biol. 22: 361 366. Exemplary inducible promoters include that from the ACE1 system which responds to copper (Mett et al., 1993, PNAS 90: 4567-4571); In2 gene promoter from maize which responds to benzenesulfonamide herbicide safeners (Hershey et al., 1991, Plant Mol. Biol. 17:679-690; and the Tet repressor from TnlO (Hersey, et al., 1991, Mol. Gen. Genetics 227:229-237; Gatz, et al., 1994, M?/.Ge«. Genetics 243:32-38). A particularly preferred inducible promoter is one that responds to an inducing agent to which plants do not normally respond. One example of such a promoter is the steroid hormone gene promoter. Transcription of the steroid hormone gene promoter is induced by glucocorticosteroid hormone. (Schena et al., 1991, PNAS U.S.A. 88: 10421) In the present invention, an expression vector comprises an inducible promoter operably linked to a nucleotide sequence encoding APOXD. The expression vector is introduced into plant cells and presumptively transformed cells are exposed to an inducer of the inducible promoter. The cells are screened for the presence of APOXD proteins by immunoassay methods or by analysis of the enzyme's activity. Pathogen-Inducible Promoters A pathogen-inducible promoter of the present invention is an inducible promoter that responds specifically to the inducing agent, oxalic acid, or to plant pathogens such as oxalic acid-producing pathogens including Sclerotinia sclerotiorum. Genes that produce transcripts in response to Sclerotinia and oxalic acid have been described in Mouley et al., 1992, Plant Science 85:51-59. One member of the prpl-1 gene family contains a promoter that is activated in potato during early stages of late blight infection and is described in Martini et al., 1993, Mol.Gen.Genet. 236: 179-186. Tissue-specific or Tissue-Preferred Promoters A tissue specific promoter of the invention is operably linked to a nucleotide sequence encoding APOXD. Optionally, the tissue-specific promoter is operably linked to a nucleotide sequence encoding a signal sequence which is operably linked to a nucleotide sequence encoding APOXD. Plants transformed with a gene encoding APOXD operably linked to a tissue specific promoter produce APOXD protein exclusively, or preferentially, in a specific tissue. Any tissue-specific or tissue-preferred promoter can be utilized in the instant invention. Examples of such promoters include a root-preferred promoter such as that from the phaseolin gene as described in Murai et al., 1983, Science 222:476-482 and in Sengupta-Gopalan et al., 1985, PNAS USA 82:3320-3324; a leaf-specific and light- induced promoter such as that from cab or rubisco as described in Simpson et al, 1985, EMBO J. 4(l l):2723-2729, and in Timko et al., 1985, Nature 318:579-582; an anther- specific promoter such as that from LAT52 as described in Twell et al., 1989, Mol. Gen. Genet. 217:240-245; a pollen-specific promoter such as that from Zml3 as described in Guerrero et al., 1990, Mol.Gen. Genet. 224:161-168; and a microspore-preferred promoter such as that from apg as described in Twell et al., 1993, Sex Plant Reprod. 6:217-224. Other tissue-specific promoters useful in the present invention include a phloem-preferred promoter such as that associated with the Arabidopsis sucrose synthase gene as described in Martin et al., 1993, The Plant Journal 4(2):367-377; a floral-specific promoter such as that of the Arabidopsis HSP 18.2 gene described in Tsukaya et al., 1993, Mol.Gen. Genet. 237:26-32 and of the Arabidopsis HMG2 gene as described in Enjuto et al., 1995, Plant Cell 7:517-527. An expression vector of the present invention comprises a tissue-specific or tissue-preferred promoter operably linked to a nucleotide sequence encoding APOXD. The expression vector is introduced into plant cells. The cells are screened for the presence of APOXD protein by immunological methods or by analysis of enzyme activity. Constitutive Promoters A constitutive promoter of the invention is operably linked to a nucleotide sequence encoding APOXD. Optionally, the constitutive promoter is operably linked to a nucleotide sequence encoding a signal sequence which is operably linked to a nucleotide sequence encoding APOXD. Many different constitutive promoters can be utilized in the instant invention to express APOXD. Examples include promoters from plant viruses such as the 35S promoter from cauliflower mosaic virus (CaMV), as described in Odell et al., 1985, Nature 313:810-812, and promoters from genes such as rice actin (McElroy et al., 1990, Plant Cell 2:163-171); ubiquitin (Christensen et al., 1989, Plant Mol. Biol. 12:619-632; and Christensen et al., 1992, Plant Mol. Biol 18:675-689); pEMU (Last et al., 1991, Theor. Appl. Genet. 81:581-588); MAS (Velten et al., 1984, EMBO J. 3:2723-2730); and maize H3 histone (Lepetit et al., 1992, Mol.Gen.Genet. 231 :276-285; and Atanassvoa et al., 1992, Plant Journal 2(3 ):291-300). The ALS promoter, a Xba/Ncol fragment 5' to the Brassica napus ALS3 structural gene, or a nucleotide sequence having substantial sequence similarity to the Xbal Ncol fragment, represents a particularly useful constitutive promoter, and is described in published PCT Application number WO 96/30530. In the present invention, an expression vector comprises a constitutive promoter operably linked to a nucleotide sequence encoding APOXD. The expression vector is introduced into plant cells and presumptively transformed cells are screened for the presence of APOXD proteins by immunoassay methods or by analysis of the enzyme's activity. Additional regulatory elements that may be connected to the APOXD nucleic acid sequence for expression in plant cells include terminators, polyadenylation sequences, and nucleic acid sequences encoding signal peptides that permit localization within a plant cell or secretion of the protein from the cell. Such regulatory elements and methods for adding or exchanging these elements with the regulatory elements of the APOXD gene are known, and include, but are not limited to, 3 'termination and/or polyadenylation regions such as those of the Agrobacterium tumefaciens nopaline synthase (nos) gene (Bevan et al., 1983, Nucl. Acids Res. l l(2):369-385); the potato proteinase inhibitor II (PIΝII) gene (Keil. et al., 1986, Nucl. Acids Res. 14:5641-5650; and An et al., 1989, Plant Cell 1:115-122); and the CaMV 19S gene (Mogen et al., 1990, Plant Cell 2:1261-1272). Plant signal sequences, including, but not limited to, signal-peptide encoding DΝA/RΝA sequences which target proteins to the extracellular matrix of the plant cell (Dratewka-Kos, et al., J. Biol. Chem. 264:4896-4900, 1989) and the Νicotiana plumbaginifolia extensin gene (DeLoose, et al., Gene 99:95-100, 1991), or signal peptides which target proteins to the vacuole like the sweet potato sporamin gene (Matsuoka, et al., PNAS 88:834, 1991) and the barley lectin gene (Wilkins, et al., Plant Cell, 2:301-313, 1990), or signals which cause proteins to be secreted such as that of PRIb (Lund, et al., Plant Mol. Biol. 18:47-53, 1992), or those which target proteins to the plastids such as that of rapeseed enoyl-Acp reductase (Verwoert, et al., Plant Mol. Biol. 26:189-202, 1994) are useful in the invention. Gene Transformation Methods Numerous methods for introducing foreign genes into plants are known and can be used to insert the APOXD gene into a plant host, including biological and physical plant transformation protocols. See, for example, Miki et al., 1993, "Procedure for Introducing Foreign DNA into Plants" in: Methods in Plant Molecular Biology and Biotechnology, Glick and Thompson, eds., CRC Press, Inc., Boca Raton, pages 67-88. The methods chosen vary with the host plant, and include chemical transfection methods such as calcium phosphate, microorganism-mediated gene transfer such as Agrobacterium (Horsch, et al., Science 227: 1229-31, 1985), electroporation, micro-injection, and biolistic bombardment. Expression cassettes and vectors and in vitro culture methods for plant cell or tissue transformation and regeneration of plants are known and available. See, for example, Gruber, et al., 1993, "Vectors for Plant Transformation" In: Methods in Plant Molecular Biology and Biotechnology, Glick and Thompson, eds., CRC Press, Inc., Boca Raton, pages 89-119. Agrobacterium-mediated Transformation The most widely utilized method for introducing an expression vector into plants is based on the natural transformation system of Agrobacterium. A. tumefaciens and A. rhizogenes are plant pathogenic soil bacteria which genetically transform plant cells. The Ti and Ri plasmids of A. tumefaciens and A. rhizogenes, respectfully, carry genes responsible for genetic transformation of plants. See, for example, Kado, 1991, Crit. Rev.Plant Sci. 10(1): 1-32. Descriptions of the Agrobacterium vector systems and methods for Agrobacterium-mediated gene transfer are provided in Gruber et al., supra; Miki, et al., supra, and Moloney, et al., 1989, Plant Cell Reports 8:238. Direct Gene Transfer Despite the fact that the host range for transformation is broad, some major cereal crop species and gymnosperms have generally be recalcitrant to this mode of gene transfer, even though some success has recently been achieved in rice (Hiei et al., 1994, The Plant Journal 6(2):271-282). Several methods of plant transformation, collectively referred to as direct gene transfer, have been developed as an alternative to Agrobacterium-mediated transformation. A generally applicable method of plant transformation is microprojectile- mediated transformation, where DNA is carried on the surface of microprojectiles measuring about 1 to 4 Tm. The expression vector is introduced into plant tissues with a biolistic device that accelerates the microprojectiles to speeds of 300 to 600 m/s which is sufficient to penetrate the plant cell walls and membranes. (Sanford et al., 1987, Part.Sci. Technol 5:27; Sanford, 1988, Trends Biotech 6:299; Sanford, 1990, Physiol. Plant 79:206; Klein et al., 1992, Biotechnology 10:268) Another method for physical delivery of DNA to plants is sonication of target cells as described in Zhang et al., 1991, Bio/Technology 9:996. Alternatively, liposome or spheroplast fusions have been used to introduce expression vectors into plants. See, for example, Deshayes et al., 1985, EMBO J. 4:2731-273 '; and Christou, et al., 1987, PNAS USA 84:3962-3966. Direct uptake of DNA into protoplasts using CaCl 2 precipitation, polyvinyl alcohol or poly-L-ornithine have also been reported. See, for example, Hain et al., 1985, Mol. Gen.Genet. 199:161; and Draper, et al., 1982, Plant & Cell Physiol. 23:451. Electroporation of protoplasts and whole cells and tissues has also been described. See, for example, D'Halluin, et al., 1992, Plant Cell 4:1495-1505; and Spencer, et al., 1994, Plant Mol.Biol. 24:51-61. Particle WoundingΛ4gro6αcferiι*m Delivery Another useful basic transformation protocol involves a combination of wounding by particle bombardment, followed by use of Agrobacterium for DNA delivery, as described by Bidney, et al. 1992, Plant Mol. Biol. 18:301-313. Useful plasmids for plant transformation include pPHP9762 shown in Figure 5. The binary backbone for pPHP9762 is pPHP6333. See Bevan, 1984, Nucleic Acids Research 12:8711-8721. This protocol is preferred for transformation of sunflower plants, and employs either the "intact meristem" method or the "split meristem" method. In general, the intact meristem transformation method (Bidney, et al., Supra) involves imbibing seed for 24 hours in the dark, removing the cotyledons and root radical, followed by culturing of the meristem explants. Twenty-four hours later, the primary leaves are removed to expose the apical meristem. The explants are placed apical dome side up and bombarded, e.g., twice with particles, followed by co-cultivation with Agrobacterium. To start the co-cultivation for intact meristems, Agrobacterium is placed on the meristem. After about a 3 -day co-cultivation period the meristems are transferred to culture medium with cefotaxime (plus kanamycin for the NPTII selection). Selection can also be done using kanamycin. The split meristem method involves imbibing seed, breaking of the cotyledons to produce a clean fracture at the plane of the embryonic axis, excising the root tip and then bisecting the explants longitudinally between the primordial leaves (Malone- Schoneberg et al., 1994, Plaiit Science 103:199-207). The two halves are placed cut surface up on the medium then bombarded twice with particles, followed by co-cultivation with Agrobacterium. For split meristems, after bombardment the meristems are placed in an Agrobacterium suspension for 30 minutes. They are then removed from the suspension onto solid culture medium for three day co-cultivation. After this period, the meristems are transferred to fresh medium with cefotaxime (plus kanamycin for selection). Transfer by Plant Breeding Alternatively, once a single transformed plant has been obtained by the foregoing recombinant DNA method, conventional plant breeding methods can be used to transfer the structural gene and associated regulatory sequences via crossing and backcrossing. Such intermediate methods will comprise the further steps of: (1) sexually crossing the disease-resistant plant with a plant from the disease-susceptible taxon; (2) recovering reproductive material from the progeny of the cross; and (3) growing disease- resistant plants from the reproductive material. Where desirable or necessary, the agronomic characteristics of the susceptible taxon can be substantially preserved by expanding this method to include the further steps of repetitively: (1) backcrossing the disease-resistant progeny with disease-susceptible plants from the susceptible taxon; and (2) selecting for expression of APOXD activity (or an associated marker gene) among the progeny of the backcross, until the desired percentage of the characteristics of the susceptible taxon are present in the progeny along with the gene imparting APOXD activity. By the term "taxon" herein is meant a unit of botanical classification of genus or lower. It thus includes genus, species, cultivars, varieties, variants and other minor taxonomic groups which lack a consistent nomenclature. Assay Methods Transgenic plant cells, callus, tissues, shoots, and transgenic plants are tested for the presence of the APOXD gene by DNA analysis (Southern blot or PCR) and for expression of the gene by immunoassay or by assay of oxalate decarboxylase activity. Tolerance to exogenous oxalic acid can also be used as a functional test of enzyme expression in transformed plants. APOXD ELISA Transgenic cells, callus, plants and the like are screened for the expression of APOXD protein by immunological assays, including ELISA. Anti- APOXD antibodies are generated against APOXD preparations by known methods and are used in typical ELISA reactions. Polyclonal anti-APOXD can, for example, detect a range of about 10- 100 pg APOXD protein in transgenic plant tissues. In a suitable method for an APOXD-ELISA assay, fresh leaf or callus tissue is homogenized and centrifuged. An aliquot of the supernatant is added to a microtiter plate with a first anti-APOXD antibody and incubated for sufficient time for antibody- antigen reaction. The bound antibody is then reacted with a second antibody linked to a marker, which marker is developed or otherwise converted to a detectable signal correlated to the amount of APOXD protein in the sample. Any of the known methods for producing antibodies and utilizing such antibodies in an immunoassay can be used to determine the amount of APOXD expressed in transgenic plant cells and tissues of the invention. Oxalate Decarboxylase Assay Transgenic cells, tissue, or plants expressing the APOXD gene are assayed for enzyme activity to verify expression of the gene. In general, the cells or tissue is frozen in liquid nitrogen, placed on a lyophilizer overnight to dehydrate, then crushed into a fine powder for use in the assay reaction. Leaf tissue is homogenized as fresh tissue in the reaction mixture, or dehydrated and treated as described above. A typical assay reaction is begun by adding 0.75 mg of powdered tissue, such as callus, to 1 ml of oxalate decarboxylase reaction mixture: 900 TI 0.2 M sodium phosphate buffer, pH 5.0, and 100 TI of 10 mM sodium oxalate, pH 5.0. The reaction is incubated at room temperature for 3 hours with gentle mixing, and is stopped by the addition of 150 TI of 1 M Tris-HCl, pH 7.0. The mixture is centrifuged, and an aliquot is placed in a cuvette with NAD (600 Tg) and formate dehydrogenase (200 Tg). The absorbance at 340 nm is correlated to the activity of the APOXD enzyme. Use of Oxalate Decarboxylase as a Selectable Marker Oxalate decarboxylase is useful in selecting successful transformants, e.g., as a selectable marker. Growth of plant cells in the presence of oxalic acid favors the survival of plant cells that have been transformed with a gene encoding an oxalate- degrading enzyme, such as APOXD. In published PCT application WO 94/13790, herein incorporated by reference, plant cells grown on a selection medium containing oxalic acid (and all of the elements necessary for multiplication and differentiation of plant cells) demonstrated selection of only those cells transformed with and expressing oxalate oxidase. In like manner, transformation and expression of the gene encoding APOXD in plant cells is used to degrade oxalic acid present in the media and allow the growth of only APOXD-gene transformed cells. Production of APOXD in Plants Trangenic plants of the present invention, expressing the APOXD gene, are used to produce oxalate decarboxylase in commercial quantities. The gene transformation and assay selection techniques described above yield a plurality of transgenic plants which are grown and harvested in a conventional manner. Oxalate decarboxylase is extracted from the plant tissue or from total plant biomass. Oxalate decarboxylase extraction from biomass is accomplished by known methods. See for example, Heney and Orr, 1981, Anal. Biochem. 114:92-96. In any extraction methodology, losses of material are expected and costs of the procedure are also considered. Accordingly, a minimum level of expression of oxalate decarboxylase is required for the process to be deemed economically worthwhile. The terms "commercial" and "commercial quantities" here denote a level of expression where at least 0.1% of the total extracted protein is oxalate decarboxylase. Higher levels of oxalate decarboxylase expression are preferred. Diagnostic Oxalate Assay Clinical measurement of oxalic acid in urine is important, for example, in the diagnosis and treatment of patients with urinary tract disorders or hyperoxaluric syndromes. The recombinant APOXD enzyme of the invention is preferably immobilized onto beads or solid support, or added in aqueous solution to a sample for quantitation of oxalate. As discussed above, oxalate decarboxylase catalyzes the conversion of oxalate to CO 2 and formic acid. A variety of detection systems can be utilized to quantify this enzyme catalyzed conversion, including methods for detecting an increase in CO 2 , or for detecting an increase in formic acid. For example, the conversion of oxalate to formic acid and CO 2 is assayed by determining formate production via the reduction of NAD in the presence of formate dehydrogenase. This method is described in Lung, et al., 1994, J. Bacteriology, 176:2468-2472 and Johnson, et al., 1964, Biochem. Biophys. Acta 89:35. A calibration curve is generated using known amounts of oxalic acid. The amount of oxalate in a specimen is extrapolated from the standard curve. Other enzymatic assays and the like are adapted by known methods to utilize the APOXD enzyme to detect conversion of oxalate. EXAMPLES The invention is described more fully below in the following Examples, which are exemplary in nature and are not intended to limit the scope of the invention in any way. Example 1 Cloning of the Gene Encoding APOXD Protein Sequence A commercial preparation of A. phoenices oxalate decarboxylase enzyme was obtained from Boehringer Mannheim. (Catalog #479 586) SDS polyacrylamide gel electrophoresis was used to determine the purity of the enzyme. Only one dark band appeared following Coomassie blue staining of the polyacrylamide gel (12.5%). This band was about 49 kd in size, as determined by comparison to molecular weight markers. Aliquots of the preparation were sent to the University of Michigan for sequence analysis by Edman degradation on an automated protein sequencer. Preparative polyacrylamide gels were run and the APOXD band was isolated from the gel prior to sequencing. The protein was first sequenced at the amino terminus. Proteins were chemically cleaved into fragments by cyanogen bromide, size separated on polyacrylamide gels, and isolated as bands on the gel for further preparation and sequencing. The results of the sequencing are shown below in Table 2. - 1. TABLE 2 Peptide Sequence* Seq. ID No. amino terminus Gin Asp Lys Pro Phe Thr Pro Asp His Arg 6 Asp Pro Tyr Asp His Lys Val Asp Ala He Gly Glu X His Glu Pro Leu fragment 1 Val He Arg Glu Leu His Trp His Arg Glu 7 Ala Gly fragment 2 Arg Leu Asp Glu Gly Val He Arg Glu Leu 8 His Cys His Arg Glu Ala Glu fragment 3 Ser Tyr Phe Lys Arg Gly Arg Ala Arg Tyr 9 Thr He Phe Ala Ala Glu Gly Asn Ala Arg fragment 4 Ser Ala His Thr Pro Pro Ser Val Leu Ala 10 Gly Asn * X = Unknown. PCR Amplification of Genomic A. phoenices Genomic DNA was used as the PCR template to amplify the APOXD sequence. Aspergillus phoenices was obtained from the American Type Culture Collection (ATCC), Rockville, MD. Cultures were established on solid potato dextrose agar medium (Difco formulation). Liquid stationary cultures were started from culture plates by innoculatory spores in a minimal growth medium previously described for the culture of Aspergillus strains (Emiliani, et al, 1964, Arch. Biochem. Biophys 105:488- 493, cited above). To isolate DNA, mycelial mats were recovered from 4-day liquid stationary cultures, washed in cold water, and blotted dry. The tissue was then frozen in liquid nitrogen, ground by mortar and pestle, and stored frozen at -80°C. DNA was extracted by the method described for fungal mycelium in Sunis et al. (eds.), 1990, PCR protocols, pages 282-287. PCR Strategy As diagrammed in Figure 1, primers were designed for both the N-terminal protein sequence and for an internal peptide fragment. One set of primers (PHN 11337 [Seq ID No. 11] and PHN 11339 [Seq ID No. 12]) was designed with nearly full degeneracy. A second set of primers (PHN 11471 [Seq. ID No. 13] and PHN 11476 [Seq ID No. 14]) was designed with no degeneracy. These were based on a codon usage table for Aspergillus niger generated using the Wisconsin Sequence Analysis Package (GCG) (Genetics Computer Group, Inc., Madison, WI). The sequences of these primers is shown in Table 3, below, and diagrammatically in Figure 1. Table 3 shows the degenerate primer mixtures using IUPAC designations, as described in Cornish-Bowden, 1985, Nucleic Acids Res. 13:3021-3030. The IUPAC nucleic acid symbols include: Y=C or T; N=A, T, C, or G; R=A or G; D=A, T, or G; and V=A, C, or G. Both of these PCR strategies were successful in amplifying a DNA fragment, shown in Table 4, having homology to the protein sequence data shown in Table 2. TABLE 3 PCR reactions were set up containing increasing quantities of A. phoenices genomic DNA, in the range of 1-10 nanograms, and various oligonucleotide primer sets. Degenerate primers were added at a ten-fold higher concentration than that standardly used, due to their degeneracy. All other conditions for PCR were standard, essentially as described in Innis, et al., 1990, PCR Protocols, pages 282-287, except for the annealing temperatures for the primers. These temperatures were determined on an individual basis using the Oligo 4.0 computer program for analysis as described in Rychlik et al., 1989, Nuc.Acids Res. 17:8543-8551. Specifically, the primers and annealing temperatures were : Transformation and Sequencing PCR amplification products were ligated into pCR II using the TA Cloning Kit (InVitrogen, San Diego, CA), and transformed into E.coli strain DH5α competent cells (Life Technologies, Gathersburg, MD) according to the protocol provided with the strain, for cloning and sequencing. Transformed bacteria with plasmid insertions were selected on medium 34Z (LB agar plates containing 100 mg/1 carbenicillin) using standard X-GAL selection protocols (Ausubel, et al., eds, 1989, Current Protocols in Molecular Biology, pages 1.0.3-1.15.8). Briefly, white colonies were picked with an inoculating loop and inoculated directly into a PCR reaction mixture containing primers specific to the universal and reverse promoter regions just outside the multiple cloning site. The remaining innoculum on the loop was used to streak a plate of 34Z medium and numbered to correspond to the PCR reaction. Successful amplification of an inserted PCR fragment resulted in a band on an ethidium bromide stained agaraose gel which was slightly larger than the size of the insert. Bacterial isolates with an insert of the correct size were inoculated into shaking liquid cultures and subsequently used for plasmid isolation protocols, followed by sequencing of the insert of interest. Sequence quality plasmid was prepared by using the Nucleobond P-100 plasmid isolation kit (Machery-Nagle GmBH & Co., Cat.No. BP 101352m distributed by the Nest Group, Southboro, MA). This kit uses an alkaline lysis step and is followed by an ion exchange silica column purification step. Plasmid and gene specific primers were sent to Iowa State University to be sequenced on an automated, ABI DNA Sequencing machine. The degenerate primer PCR experiment resulted in the amplification of a 0.4 kb band, which was sequenced and determined to have a deduced amino acid sequence matching the protein data in Table 2. The non-degenerate primer experiment resulted in DNA fragments of various sizes. One fragment was about 0.4 kb in length and encoded a protein having homology to the protein sequence data of Table 2. The region of the APOXD gene that was amplified by both primer sets was nearly the same, so DNA sequence data for the amplified fragments was compiled, and the sequence of the compiled APOXD genomic fragment is shown in Table 4 [Seq ID No. 15] together with its deduced amino acid sequence [Seq ID Nos. 16 and 29]. The underlined amino acid sequences were represented in the original protein sequence analysis data (Table 2). TABLE 4 APOXD FRAGMENT 10 20 30 40 ACG ATC ACA AGG TGG ATG CGA TCG GGG AAG GCC ATG AGC CCT TGC CCT Asp His Lys Val Asp Ala He Gly Glu Gly His Glu Pro Leu Pro 50 60 70 80 90 GGC GCA TGG GAG ATG GAG CCA CCA TCA TGG GAC CCC GCA ACA AGG ACC Trp Arg Met Gly Asp Gly Ala Thr He Met Gly Pro Arg Asn Lys Asp 100 110 120 130 140 GTG AGC GCC AGA ACC CCG ACA TGC TCC GTC CTC CGA GCA CCG ACC ATG Arg Glu Arg Gin Asn Pro Asp Met Leu Arg Pro Pro Ser Thr Asp His 150 160 170 180 190 GCA ACA TGC CGA ACA TGC GGT GGA GCT TTG CTG ACT CCC ACA TTC GCA Gly Asn Met Pro Asn Met Arg Trp Ser Phe Ala Asp Ser His He Arg 200 210 220 230 240 TCG AGG TAA GCC CTT CGA GGG TTT TGT GTA CGA CAA GCA AAA TAG GCT He Glu 250 260 270 280 AAT GCA CTG CAG GAG GGC GGC TGG ACA CGC CAG ACT ACC GTA CGC GAG Gly Trp Thr Arg Gin Thr Thr Val Arg Glu 290 300 310 320 330 CTG CCA ACG AGC AAG GAG CTT GCG GGT GTA AAC ATG CGC CTC GAT GAG Leu Pro Thr Ser Lys Glu Leu Ala Gly Val Asn Met Arg Leu Asp Glu 340 350 360 370 380 GGT GTC ATC CGC GAG TTG CAC TGG CAA GGG CTG AAG GCG AAT TCC AGC Gly Val He Arg Glu Leu His Trp 390 400 410 420 430 ACA CTG GCG GCC GTT ACT AGT GGA TCC GAG CTC GGT ACC AAG CTT GAT GC ATAGCT 3' RACE Nested oligonucleotide primers were designed based on the genomic DNA sequence fragment which was previously amplified (Table 4) and used for 3' RACE to enhance gene specific amplification. The nested primer design is diagrammatically shown in Figure 2 and the nucleic acid sequences of the primers is shown below in Table 5. Arrows represent the gene specific primers (from top to bottom) PHN 11811, PHN 1 1810, and the oligo dT based 3' primer from a commercially supplied 3' RACE kit (Life Technologies, Gaithersburg, MD, Cat. No. 18373-019) TABLE 5 The first round of PCR amplification using the outside gene specific primer (GSP) PHN11810 and the oligo dT based 3' primer resulted in no visible DNA bands. The inside GSP PHN11811 and the oligo dT based 3' primer were then used for a second round of amplification on the same sample. A large number of bands appeared, some of which stained intensely with ethidium bromide and some which did not. The prominent bands were 0.4, 0.8 and 1.3 kb in size. This experiment was set up using 5' and 3' primers with custom ends which only allow ligation of DNA fragments amplified by both. This method permitted the reaction to be used in the ligation protocol without further purification or characterization of the DNA fragments. All three of the prominent bands described above were ligated into pAMPI (Life Technologies, Cat. No., 18384-016), transformed into DH5α cells (Life Technologies, Cat. No. 18263-12), cloned and sequenced. The 0.4 kb band was found to encode an amino acid sequence having homology to the APOXD sequence data of Table 1. 5' RACE Total RNA was reverse transcribed with commercially available components and a set of oligo dT-based primers ending in G, C or A which are collectively termed Bam T17V (5' CGC GGA TCC GT 17 V) 3') [Seq ID No. 19] These primers are disclosed in published PCT Application No. US96/08582. First strand cDNA was oligo dC-tailed and then column purified using commercially available components. (Life Technologies, Gaithersburg). The product of this reaction was then used in PCR with primer set Bam G13H, an equimolar mixture of oligo dG primers ending in A, C, or T (5' TAA GGA TCC TG 13 H 3') [Seq. ID NO: 20], and a second gene specific primer, PHN 11813 [Seq ID No. 21]. Amplified products were characterized by Southern analysis using the protocol as described in Ausubel, et al. (eds.), 1989, Current Protocols in Molecular Biology, pages 2.0.1 - 2.12.5. Hybridization of the 5 1 RACE product was done using the PCR amplified genomic DNA fragment (Table 4) as a radiolabeled probe. A 0.6 kb band was amplified by this reaction and was strongly labeled with the probe. No other bands appeared. This 0.6 kb band was ligated into the PCR II vector using the TA-cloning procedure, transformed into DH5I, cloned and sequenced. The DNA sequence analysis of the 0.6 kb PCR fragment showed it was homologous to the APOXD sequence data shown in Table 2. TABLE 6 IUPAC Symbols: V=G,C, or A; H=A, T, or C. PCR For Full Length The 5' and 3' RACE products were sequenced to their ends as determined by the initiating methionine and the poly-A tail respectively. DNA sequence at each end was analyzed by Oligo 4.0 for oligonucleotide primer design in preparation for PCR to obtain the complete gene. Primer PHN 12566 designed to the 3' end of the sequence, was used to reverse transcribe total RNA. Primers PHN 12565 and PHN 12567 were used to amplify first strand cDNA. The PCR amplified band was ligated into PCR II using the T A cloning kit (In Vitrogen; San Diego, CA) then transformed into DH5I, cloned, and sequenced. TABLE 7 A 1.4 kb band was amplified which stained very intensely with ethidium bromide. Other, smaller bands were present, but clearly, the 1.4 kb band was prominent. This band was sequenced and subjected to open reading frame analysis. All of the protein fragments originally sequenced (Table 2), were found in the deduced amino acid sequence of this PCR product. Southern analysis was performed on genomic DNA using the 1.4 kb cDNA as a radiolabeled probe. Only one band hybridized, suggesting that the gene is a single copy and unique in the A. phoenices genome. Table 1 (pages 4-7) shows the full length cDNA sequence [Seq ID No:l] and deduced amino acid sequence [Seq ID No: 2] of the A. phoenices oxalate decarboxylase gene as amplified, using PCR primers PHN 12565 and PHN 12567. The underlined amino acid sequences were represented in the original protein sequence analysis data (Table 2). The protein sequence encoded by the full length cDNA includes a pre- protein, amino acid residues 27-458 [Seq ID No:4], and a mature protein, amino acid residues 50-458 [Seq ID No:5]. Example 2 Transformed plant tissue degrades oxalate CaMV35S/O7APOXD The insert of pPHP9685 (1.4 kb APOXD cDNA in pCR II) was placed into a cloning vector intermediate (pLitmus 28, New England Biolabs) between a plant expressible promoter and 3' region as shown in the construction diagrams of Figure 3. The upstream region consists of a cauliflower mosaic virus 35S promoter with a duplicated enhancer region (2X35S; bases -421 to -90 and -421 to +2, Gardner, et al., 1985, Nucleic Acids Res. 9:2871-2888) with a flanking 5' Notl site and a 3' Pst site, and Ω' RΝA leader sequence. The 3' region is from potato proteinase inhibitor II. These are described in Bidney, et al., 1992, Plant Mol. Biol. 18:301-313. The 2X CaMV 35S promoter is described in Odell, et al., Nature 313:810-812. The plant-expressible APOXD gene cassette was then isolated from the cloning intermediate and ligated into the ALS::ΝPT II:: PIN ϋ-containing pBIN19 construct, pPHP8110. Plasmid pPHP8110 was created from pBIN 19 (Bevan, 1984, Nucleic Acids Res. 12:8711-8721) by replacing the NOS::NPTII::NOS gene cassette in pBIN19 with an ALS::NPTII::PINII cassette. As shown in Figure 3, pPHP8110 is a derivative of pBI 19 containing the NPT II gene, the aminoglycoside-3'-O- phosphotransferase coding sequence, bases 1551 to 2345 from Ecoli transposon TN5 (Genbank Accession Number V00004, Beck, et al., 1982, Gene 19:327-336). The second amino acid was modified from an isoleucine to a valine in order to create a Nco I restriction site which was used to make a translational fusion with the ALS promoter (see copending U.S. Patent Application Serial No. 08/409,297). pPHP8110 further contains the potato proteinase inhibitor II terminator (PIN II) bases 2-310, as described in An, et al., 1989, Plant Cell 1:115-122. As shown in Figure 4, the resultant plasmid, pPHP9723, carries the APOXD gene construct, together with the NPTII gene for selection of transgenic plant cells, positioned between Agrobacterium T-DNA borders. Ger in/APOXD A second APOXD cDNA containing plasmid was constructed using the methods described above for producing pPHP 9723. In the second construct, the APOXD fungal signal and presequence (49 amino acids) were replaced with a plant signal sequence obtained from the 5' end of an enzyme subunit of wheat oxalate oxidase. (Lane, et al., 1991, J. Biol. Chem. 266:10461.) This was accomplished by designing primers that were homologous to the Germin signal sequence, and having extensions to provide the addition of a Sal I restriction site at the 5' end and APOXD 5' sequence followed by a Nru I site at the 3' end. The primers were used to amplify the Germin signal sequence and are shown below in Table 8. Table 8 The amplified Germin signal sequence product [Seq ID NO:27] shown below in Table 9, and a vector containing the full length APOXD cDNA (ρPHP9648) were each digested with Sal I and Nru I. A ligation reaction was set up with the digested fragments to form a Germin signal sequence - APOXD coding sequence fusion construct. Clones of the correct size were sequenced to verify correct results. As shown in Table 9, the SaWNrul cut Germin SS - containing sequence also contained modified APOXD codons matched to fill in the NrwI-cut APOXD sequence. The Germin signal sequence [Seq. ID No: 28] is shown in lower case. Table 9 Amplified Germin Signal/APOXD Sequence* 1 GCAGCTTATT TTTACAACAA TTACCAACAA CAACAAACAA AAACAACAT Sail start 51 TACAATTACT ATTTACAATT ACAGTCGACC CGGGATCC atg ggt tac 98 tea aag ace ttg gtt get ggt ttg ttc get atg ttg ttg 137 ttg get cea get gtt ttg get ace ICAG GAT AAG CCT TTC Nrul 176 ACC CCA GAT CAT CGC GA CCCCTATG ATCACAAGGT GGATGCGATC 221 GGGGAAGGCC ATGAGCCCTT GCCCTGGCGC ATGGGAGATG GAGCCACCAT 271 CATGGGACCC CGCAACAAGG ACCGTGAGCG CCAGAACCCC GACATGCTCC 311 GTCCTCCGAG CACCGACCAT GGCAACATGC CGAACATGCG GTGGAGCTTT 361 GCTGACTCCC ACATTCGCAT CGAGGAGGGC GGCTGGACAC GCCAGACTAC 411 CGTACGCGAG CTGCCAACGA GCAAGGAGCT TGCGGGTGTA AACATGCGCC 461 TCGATGAGGG TGTCATCCGC GAGTTGCACT GGCATCGA *The Sail (GTCGAC) and Nrul (TCGCGA) restriction sites are underlined, the Germin signal sequence is in lower case, with the Germin start site in bold. APOXD sequences modified in the PCR primer design are shown in bold. This fusion gene was placed in the binary T-DNA plasmid to produce plasmid pPHP9762 carrying the fusion gene and the plant expressible NPTII gene positioned between Agrobacterium T-DNA borders, as described above. Agrobacterium tumefaciens strain EHA105 (as described in Hood, et al., 1993, Transgen. Res. 2:208-218) was transformed with kanamycin resistant binary T- DNA vectors carrying the different versions of APOXD. Transformation was accomplished by the freeze-thaw method of Holsters, et al., 1978, Mol. Gen. Genetics 1:181-7. The transformed isolates were selected on solidified 60A (YEP; lO g/1 yeast extract, 10 g/1 bactopeptone, 5 g/1 NaCl, pH 7.0) medium with 50 mg/1 kanamycin. Transformed bacteria were cultured in liquid culture of YEP medium containing 50 mg/1 kanamycin, to log phase growth (O.D. 6 oo 0.5-1.0) for use in plant transformations. Binary plasmids were re-isolated from transformed Agrobacterium to verify that integrity was maintained throughout the transformation procedures. Sunflower leaf discs were obtained by harvesting leaves which were not fully expanded, sterilizing the surface in 20% bleach with TWEEN 20, and punching discs out of the leaf with a paper punch. Agrobacterium suspensions were centrifuged and resuspended in inoculation medium (12.5 μM MES buffer, pH 5.7, 1 g/1 NH t Cl, 0.3 g/1 MgSO ) to a calculated OD 6 oo of 0.75 as described in Malone-Schoneberg, et al., 1994, Plant Science 103: 199-207. Leaf discs were inoculated in the resuspended Agrobacterium for 10 minutes then blotted on sterile filter paper. The tissue and bacteria were co-cultivated on 527 for 3 days, then transferred to 527E medium for the selection of transgenic plant cells. After 2 weeks of culture, the transgenic callus nodes were removed from the leaf disc and subcultured on fresh 527E medium. A number of subcultures were repeated prior to the assay of the callus tissue for enzyme activity. To assay for enzyme activity, callus was harvested, snap frozen in liquid nitrogen, lyophilized to dryness and powdered. A quantity of 0.75 mg of powder from each prepared callus line was added to 1.0 ml reaction mixture (900 μl 200 mM NaPO , pH 5.0, 100 μl 10 mM Na-oxalate pH 5.0). The reaction proceeded for 3 hours at room temperature and was stopped by the addition of 150 μl of 1M TRIS-HC1, pH 7.0. Each sample was spun at 14,000 rpm for one minute and 1 ml was removed to a cuvette. One hundred (100) μl of θ-NAD (6.6 mg/ml stock) and 50 μl formate dehydrogenase (4.0 mg/ml stock) were added and the increase in absorbance was measured at 340 nm. A slope was generated for each sample as well as for a formate standard curve. Assay results were reported as μM oxalate metabolized /mg powder. The results of the leaf disk assay are shown below in Table 10, and demonstrate that the APOXD gene sequence produces enzyme that is active in transgenic callus. No activity was seen in control callus, or callus transformed with the native APOXD gene (pPHP 9723). Table 10 Example 3 Transgenic Sunflower Plants Expressing APOXD Sunflower plants were transformed using a basic transformation protocol involving a combination of wounding by particle bombardment, followed by use of Agrobacterium for DNA delivery, as described by Bidney, et al. Plant Mol. Biol. 18:301- 313. The plasmid pPHP9762, as described above for Example 2 and shown in Figure 5, was used in these experiments. pPHP9762 contains the APOXD gene with the fungal signal and presequence replaced with the Germin signal sequence and a plant expressible NPTII gene which provides kanamycin resistance to transgenic plant tissues. Procedures for preparation of Agrobacterium and preparation of particles for wounding are described in Bidney, et al., 1992, Plant Mol. Biol. 18:301-313. The Pioneer sunflower line SMF3, used in these experiments, is described in Burrus, et al., 1991, Plant Cell Rep. 10:161-166. The Agrobacterium strain used in these experiments, EHA 105. Procedures for use of the helium gun, intact meristem preparation, tissue culture and co-cultivation conditions, as well as recovery of transgenic plants, are described in Bidney, et al., 1992, Plant Mol. Biol. 18:301-313. Sunflower explants were prepared by imbibing seed overnight, removing the cotyledons and radical tip, then culturing overnight on medium containing plant growth regulators. Primary leaves were then removed and explants arranged in the center of a petri plate for bombardment. The PDS 1000 helium-driven particle bombardment device (Bio-Rad) was used with 600 psi rupture discs and a vacuum of 26 inches, Hg to bombard meristem explants twice on the highest shelf position. Following bombardment, log phase Agrobacterium cultures transformed with the APOXD-plasmid pPHP 9762, as described for Example 2, were centrifuged and resuspended at a calculated OD600 (vis) of 4.0 in inoculation buffer. Agrobacterium was then dropped onto the meristem explants using a fine tipped pipettor. Inoculated explants were co-cultured for three days then transferred to medium containing 50 mg/1 kanamycin and 250 mg/1 cefotaxime for selection. Explants were cultured on this medium for two weeks then transferred to the same medium, but lacking kanamycin. Green, kanamycin-resistant shoots were recovered to the greenhouse and assayed by an NPTII ELISA assay to verify transformation. Oxalate decarboxylase enzyme assays are performed on these plants and/or progeny to confirm the expression of APOXD. The invention has been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention. SEQUENCE LISTING (1) GENERAL INFORMATION (i) APPLICANT: SCELONGE, CHRISTOPHER BIDNEY, DENNIS (ii) TITLE OF THE INVENTION: GENE ENCODING OXALATE DECARBOXYLASE FROM ASPERGILLUS PHOENICES (iii) NUMBER OF SEQUENCES: 29 (iv) CORRESPONDENCE ADDRESS :Merchant , Gould, Smith, Edell, Welter & Schmidt (A) ADDRESSEE: Denise M. Kettelberger, Ph.D. (B) STREET: 90 South Seventh Street 3100 Norwest Center (C) Minneapolis, (D) STATE: MN (E) COUNTRY: USA (F) ZIP: 55402 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Diskette (B) COMPUTER: IBM Compatible (C) OPERATING SYSTEM: DOS (D) SOFTWARE: FastSEQ Version 2.0 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: March 21, 1997 (C) CLASSIFICATION: (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Denise M. Kettelberger, Ph.D. (B) REGISTRATION NUMBER: 33,924 (C) REFERENCE/DOCKET NUMBER: 9933.2-US-01 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 612/332-5300 (B) TELEFAX: 512/332-9081 (C) TELEX: (2) INFORMATION FOR SEQ ID NO : 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1437 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: Coding Sequence (B) LOCATION: 24...1397 (D) OTHER INFORMATION: (A) NAME/KEY: sigjpeptide (B) LOCATION: 24...101 (D) OTHER INFORMATION: (A) NAME/KEY: mat_ )eptide (B) LOCATION: 171...1397 (D) OTHER INFORMATION: (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 1 : GGCTTGTCAG GATCCTTCCA AAG ATG CAG CTA ACC CTG CCA CCA CGT CAG CTG 53 Met Gin Leu Thr Leu Pro Pro Arg Gin Leu 1 5 10 TTG CTG AGT TTC GCG ACC GTG GCC GCC CTC CTT GAT CCA AGC CAT GGA 101 Leu Leu Ser Phe Ala Thr Val Ala Ala Leu Leu Asp Pro Ser His Gly 15 20 25 GGC CCG GTC CCT AAC GAA GCG TAC CAG CAA CTA CTG CAG ATT CCC GCC 149 Gly Pro Val Pro Asn Glu Ala Tyr Gin Gin Leu Leu Gin lie Pro Ala 30 35 40 TCA TCC CCA TCC ATT TTC TTC CAA GAC AAG CCA TTC ACC CCC GAT CAT 197 Ser Ser Pro Ser He Phe Phe Gin Asp Lys Pro Phe Thr Pro Asp His 45 50 55 CGC GAC CCC TAT GAT CAC AAG GTG GAT GCG ATC GGG GAA GGC CAT GAG 245 Arg Asp Pro Tyr Asp His Lys Val Asp Ala He Gly Glu Gly His Glu 60 65 70 CCC TTG CCC TGG CGC ATG GGA GAT GGA GCC ACC ATC ATG GGA CCC CGC 293 Pro Leu Pro Trp Arg Met Gly Asp Gly Ala Thr He Met Gly Pro Arg 75 80 85 90 AAC AAG GAC CGT GAG CGC CAG AAC CCC GAC ATG CTC CGT CCT CCG AGC 341 Asn Lys Asp Arg Glu Arg Gin Asn Pro Asp Met Leu Arg Pro Pro Ser 95 100 105 ACC GAC CAT GGC AAC ATG CCG AAC ATG CGG TGG AGC TTT GCT GAC TCC 389 Thr Asp His Gly Asn Met Pro Asn Met Arg Trp Ser Phe Ala Asp Ser 110 115 120 CAC ATT CGC ATC GAG GAG GGC GGC TGG ACA CGC CAG ACT ACC GTA CGC 437 His He Arg He Glu Glu Gly Gly Trp Thr Arg Gin Thr Thr Val Arg 125 130 135 GAG CTG CCA ACG AGC AAG GAG CTT GCG GGT GTA AAC ATG CGC CTC GAT 485 Glu Leu Pro Thr Ser Lys Glu Leu Ala Gly Val Asn Met Arg Leu Asp 140 145 150 GAG GGT GTC ATC CGC GAG TTG CAC TGG CAT CGA GAA GCA GAG TGG GCG 533 Glu Gly Val He Arg Glu Leu His Trp His Arg Glu Ala Glu Trp Ala 155 160 165 170 TAT GTG CTG GCC GGA CGT GTA CGA GTG ACT GGC CTT GAC CTG GAG GGA 581 Tyr Val Leu Ala Gly Arg Val Arg Val Thr Gly Leu Asp Leu Glu Gly 175 180 185 GGC AGC TTC ATC GAC GAC CTA GAA GAG GGT GAC CTC TGG TAC TTC CCA 629 Gly Ser Phe He Asp Asp Leu Glu Glu Gly Asp Leu Trp Tyr Phe Pro 190 195 200 TCG GGC CAT CCC CAT TCG CTT CAG GGT CTC AGT CCT AAT GGC ACC GAG 677 Ser Gly His Pro His Ser Leu Gin Gly Leu Ser Pro Asn Gly Thr Glu 205 210 215 TTC TTA CTG ATC TTC GAC GAT GGA AAC TTT TCC GAG GAG TCA ACG TTC 725 Phe Leu Leu He Phe Asp Asp Gly Asn Phe Ser Glu Glu Ser Thr Phe 220 225 230 TTG TTG ACC GAC TGG ATC GCA CAT ACA CCC AAG TCT GTC CTC GCC GGA 773 Leu Leu Thr Asp Trp He Ala His Thr Pro Lys Ser Val Leu Ala Gly 235 240 245 250 AAC TTC CGC ATG CGC CCA CAA ACA TTT AAG AAC ATC CCA CCA TCT GAA 821 Asn Phe Arg Met Arg Pro Gin Thr Phe Lys Asn He Pro Pro Ser Glu 255 260 265 AAG TAC ATC TTC CAG GGC TCT GTC CCA GAC TCT ATT CCC AAA GAG CTC 869 Lys Tyr He Phe Gin Gly Ser Val Pro Asp Ser He Pro Lys Glu Leu 270 275 280 CCC CGC AAC TTC AAA GCA TCC AAG CAG CGC TTC ACG CAT AAG ATG CTC 917 Pro Arg Asn Phe Lys Ala Ser Lys Gin Arg Phe Thr His Lys Met Leu 285 290 295 GCT CAA AAA CCC GAA CAT ACC TCT GGC GGA GAG GTG CGC ATC ACA GAC 965 Ala Gin Lys Pro Glu His Thr Ser Gly Gly Glu Val Arg He Thr Asp 300 305 310 TCG TCC AAC TTT CCC ATC TCC AAG ACG GTC GCG GCC GCC CAC CTG ACC 1013 Ser Ser Asn Phe Pro He Ser Lys Thr Val Ala Ala Ala His Leu Thr 315 320 325 330 ATT AAC CCG GGT GCT ATC CGG GAG ATG CAC TGG CAT CCC AAT GCG GAT 1061 He Asn Pro Gly Ala He Arg Glu Met His Trp His Pro Asn Ala Asp 335 340 345 GAA TGG TCC TAC TTT AAG CGC GGT CGG GCG CGA GTG ACT ATC TTC GCT 1109 Glu Trp Ser Tyr Phe Lys Arg Gly Arg Ala Arg Val Thr He Phe Ala 350 355 * ' 360 GCT GAA GGT AAT GCT CGT ACG TTC GAC TAC GTA GCG GGA GAT GTG GGC 1157 Ala Glu Gly Asn Ala Arg Thr Phe Asp Tyr Val Ala Gly Asp Val Gly 365 370 375 ATT GTT CCT CGC AAC ATG GGT CAT TTC ATT GAG AAC CTT AGT GAT GAC 1205 He Val Pro Arg Asn Met Gly His Phe He Glu Asn Leu Ser Asp Asp 380 385 390 GAG AGG TCG AGG TGT TGG AAA TCT TCC GGG CGG ACC GAT TCC GGG ACT 1253 Glu Arg Ser Arg Cys Trp Lys Ser Ser Gly Arg Thr Asp Ser Gly Thr 395 400 405 410 TTT CTT TGT TCC AGT GGA TGG GAG AGA CGC CGC AGC GGA TGG TGG CAG 1301 Phe Leu Cys Ser Ser Gly Trp Glu Arg Arg Arg Ser Gly Trp Trp Gin 415 420 425 AGC ATG TGT TTA AGG ATG ATC CAG ATG CGG CCA GGG AGT TCC TTA AGA 1349 Ser Met Cys Leu Arg Met He Gin Met Arg Pro Gly Ser Ser Leu Arg 430 435 440 GTG TGG AGA GTG GGG AGA AGG ATC CAA TTC GGA GCC CAA GTG AGT AGA T 1398 Val Trp Arg Val Gly Arg Arg He Gin Phe Gly Ala Gin Val Ser Arg 445 450 455 GAGGTTCTAC GCGTGTATTT TGCTGATATC ATCGAAGCC 1437 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 458 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (v) FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 2 : Met Gin Leu Thr Leu Pro Pro Arg Gin Leu Leu Leu Ser Phe Ala Thr 1 5 10 15 Val Ala Ala Leu Leu Asp Pro Ser His Gly Gly Pro Val Pro Asn Glu 20 25 30 Ala Tyr Gin Gin Leu Leu Gin He Pro Ala Ser Ser Pro Ser He Phe 35 40 45 Phe Gin Asp Lys Pro Phe Thr Pro Asp His Arg Asp Pro Tyr Asp His 50 55 60 Lys Val Asp Ala He Gly Glu Gly His Glu Pro Leu Pro Trp Arg Met 65 70 75 80 Gly Asp Gly Ala Thr He Met Gly Pro Arg Asn Lys Asp Arg Glu Arg 85 90 95 Gin Asn Pro Asp Met Leu Arg Pro Pro Ser Thr Asp His Gly Asn Met 100 105 110 Pro Asn Met Arg Trp Ser Phe Ala Asp Ser His He Arg He Glu Glu 115 120 125 Gly Gly Trp Thr Arg Gin Thr Thr Val Arg Glu Leu Pro Thr Ser Lys 130 135 140 Glu Leu Ala Gly Val Asn Met Arg Leu Asp Glu Gly Val He Arg Glu 145 150 155 160 Leu His Trp His Arg Glu Ala Glu Trp Ala Tyr Val Leu Ala Gly Arg 165 170 175 Val Arg Val Thr Gly Leu Asp Leu Glu Gly Gly Ser Phe He Asp Asp 180 185 190 Leu Glu Glu Gly Asp Leu Trp Tyr Phe Pro Ser Gly His Pro His Ser 195 200 205 Leu Gin Gly Leu Ser Pro Asn Gly Thr Glu Phe Leu Leu He Phe Asp 210 215 220 Asp Gly Asn Phe Ser Glu Glu Ser Thr Phe Leu Leu Thr Asp Trp He 225 230 235 240 Ala His Thr Pro Lys Ser Val Leu Ala Gly Asn Phe Arg Met Arg Pro 245 250 255 Gin Thr Phe Lys Asn He Pro Pro Ser Glu Lys Tyr He Phe Gin Gly 260 265 270 Ser Val Pro Asp Ser He Pro Lys Glu Leu Pro Arg Asn Phe Lys Ala 275 280 285 Ser Lys Gin Arg Phe Thr His Lys Met Leu Ala Gin Lys Pro Glu His 290 295 300 Thr Ser Gly Gly Glu Val Arg He Thr Asp Ser Ser Asn Phe Pro He 305 310 315 320 Ser Lys Thr Val Ala Ala Ala His Leu Thr He Asn Pro Gly Ala He 325 330 335 Arg Glu Met His Trp His Pro Asn Ala Asp Glu Trp Ser Tyr Phe Lys 340 345 350 Arg Gly Arg Ala Arg Val Thr He Phe Ala Ala Glu Gly Asn Ala Arg 355 360 365 Thr Phe Asp Tyr Val Ala Gly Asp Val Gly He Val Pro Arg Asn Met 370 375 380 Gly His Phe He Glu Asn Leu Ser Asp Asp Glu Arg Ser Arg Cys Trp 385 390 395 400 Lys Ser Ser Gly Arg Thr Asp Ser Gly Thr Phe Leu Cys Ser Ser Gly 405 410 415 Trp Glu Arg Arg Arg Ser Gly Trp Trp Gin Ser Met Cys Leu Arg Met 420 425 430 He Gin Met Arg Pro Gly Ser Ser Leu Arg Val Trp Arg Val Gly Arg 435 440 445 Arg He Gin Phe Gly Ala Gin Val Ser Arg 450 455 ( ) INFORMATION FOR SEQ ID NO : 3 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N-terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 3 : Met Gin Leu Thr Leu Pro Pro Arg Gin Leu Leu Leu Ser Phe Ala Thr 1 5 10 15 Val Ala Ala Leu Leu Asp Pro Ser His Gly 20 25 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 432 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N-terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: Gly Pro Val Pro Asn Glu Ala Tyr Gin Gin Leu Leu Gin He Pro Ala 1 5 10 15 Ser Ser Pro Ser He Phe Phe Gin Asp Lys Pro Phe Thr Pro Asp His 20 25 30 Arg Asp Pro Tyr Asp His Lys Val Asp Ala He Gly Glu Gly His Glu 35 40 45 Pro Leu Pro Trp Arg Met Gly Asp Gly Ala Thr He Met Gly Pro Arg 50 55 60 Asn Lys Asp Arg Glu Arg Gin Asn Pro Asp Met Leu Arg Pro Pro Ser 65 70 75 80 Thr Asp His Gly Asn Met Pro Asn Met Arg Trp Ser Phe Ala Asp Ser 85 90 95 His He Arg He Glu Glu Gly Gly Trp Thr Arg Gin Thr Thr Val Arg 100 105 110 Glu Leu Pro Thr Ser Lys Glu Leu Ala Gly Val Asn Met Arg Leu Asp 115 120 125 Glu Gly Val He Arg Glu Leu His Trp His Arg Glu Ala Glu Trp Ala 130 135 140 Tyr Val Leu Ala Gly Arg Val Arg Val Thr Gly Leu Asp Leu Glu Gly 145 150 155 160 Gly Ser Phe He Asp Asp Leu Glu Glu Gly Asp Leu Trp Tyr Phe Pro 165 170 175 Ser Gly His Pro His Ser Leu Gin Gly Leu Ser Pro Asn Gly Thr Glu 180 185 190 Phe Leu Leu He Phe Asp Asp Gly Asn Phe Ser Glu Glu Ser Thr Phe 195 200 205 Leu Leu Thr Asp Trp He Ala His Thr Pro Lys Ser Val Leu Ala Gly 210 215 220 Asn Phe Arg Met Arg Pro Gin Thr Phe Lys Asn He Pro Pro Ser Glu 225 230 235 240 Lys Tyr He Phe Gin Gly Ser Val Pro Asp Ser He Pro Lys Glu Leu 245 250 255 Pro Arg Asn Phe Lys Ala Ser Lys Gin Arg Phe Thr His Lys Met Leu 260 265 270 Ala Gin Lys Pro Glu His Thr Ser Gly Gly Glu Val Arg He Thr Asp 275 280 285 Ser Ser Asn Phe Pro He Ser Lys Thr Val Ala Ala Ala His Leu Thr 290 295 300 He Asn Pro Gly Ala He Arg Glu Met His Trp His Pro Asn Ala Asp 305 310 315 320 Glu Trp Ser Tyr Phe Lys Arg Gly Arg Ala Arg Val Thr He Phe Ala 325 330 335 Ala Glu Gly Asn Ala Arg Thr Phe Asp Tyr Val Ala Gly Asp Val Gly 340 345 350 He Val Pro Arg Asn Met Gly His Phe He Glu Asn Leu Ser Asp Asp 355 360 365 Glu Arg Ser Arg Cys Trp Lys Ser Ser Gly Arg Thr Asp Ser Gly Thr 370 375 380 Phe Leu Cys Ser Ser Gly Trp Glu Arg Arg Arg Ser Gly Trp Trp Gin 385 390 395 400 Ser Met Cys Leu Arg Met He Gin Met Arg Pro Gly Ser Ser Leu Arg 405 410 415 Val Trp Arg Val Gly Arg Arg He Gin Phe Gly Ala Gin Val Ser Arg 420 425 430 (2) INFORMATION FOR SEQ ID NO : 5 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 409 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N-terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: Gin Asp Lys Pro Phe Thr Pro Asp His Arg Asp Pro Tyr Asp His Lys 1 5 10 15 Val Asp Ala He Gly Glu Gly His Glu Pro Leu Pro Trp Arg Met Gly 20 25 30 Asp Gly Ala Thr He Met Gly Pro Arg Asn Lys Asp Arg Glu Arg Gin 35 40 45 Asn Pro Asp Met Leu Arg Pro Pro Ser Thr Asp His Gly Asn Met Pro 50 55 60 Asn Met Arg Trp Ser Phe Ala Asp Ser His He Arg He Glu Glu Gly 65 70 75 80 Gly Trp Thr Arg Gin Thr Thr Val Arg Glu Leu Pro Thr Ser Lys Glu 85 90 95 Leu Ala Gly Val Asn Met Arg Leu Asp Glu Gly Val He Arg Glu Leu 100 105 110 His Trp His Arg Glu Ala Glu Trp Ala Tyr Val Leu Ala Gly Arg Val 115 120 125 Arg Val Thr Gly Leu Asp Leu Glu Gly Gly Ser Phe He Asp Asp Leu 130 135 140 Glu Glu Gly Asp Leu Trp Tyr Phe Pro Ser Gly His Pro His Ser Leu 145 150 155 160 Gin Gly Leu Ser Pro Asn Gly Thr Glu Phe Leu Leu He Phe Asp Asp 165 170 175 Gly Asn Phe Ser Glu Glu Ser Thr Phe Leu Leu Thr Asp Trp He Ala 180 185 190 His Thr Pro Lys Ser Val Leu Ala Gly Asn Phe Arg Met Arg Pro Gin 195 200 205 Thr Phe Lys Asn He Pro Pro Ser Glu Lys Tyr He Phe Gin Gly Ser 210 215 220 Val Pro Asp Ser He Pro Lys Glu Leu Pro Arg Asn Phe Lys Ala Ser 225 230 235 240 Lys Gin Arg Phe Thr His Lys Met Leu Ala Gin Lys Pro Glu His Thr 245 250 255 Ser Gly Gly Glu Val Arg He Thr Asp Ser Ser Asn Phe Pro He Ser 260 265 270 Lys Thr Val Ala Ala Ala His Leu Thr He Asn Pro Gly Ala He Arg 275 280 285 Glu Met His Trp His Pro Asn Ala Asp Glu Trp Ser Tyr Phe Lys Arg 290 295 300 Gly Arg Ala Arg Val Thr He Phe Ala Ala Glu Gly Asn Ala Arg Thr 305 310 315 320 Phe Asp Tyr Val Ala Gly Asp Val Gly He Val Pro Arg Asn Met Gly 325 330 335 His Phe He Glu Asn Leu Ser Asp Asp Glu Arg Ser Arg Cys Trp Lys 340 345 350 Ser Ser Gly Arg Thr Asp Ser Gly Thr Phe Leu Cys Ser Ser Gly Trp 355 360 365 Glu Arg Arg Arg Ser Gly Trp Trp Gin Ser Met Cys Leu Arg Met He 370 375 380 Gin Met Arg Pro Gly Ser Ser Leu Arg Val Trp Arg Val Gly Arg Arg 385 390 395 400 He Gin Phe Gly Ala Gin Val Ser Arg 405 (2) INFORMATION FOR SEQ ID NO : 6 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N- terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 6 : Gin Asp Lys Pro Phe Thr Pro Asp His Arg Asp Pro Tyr Asp His Lys 1 5 10 15 Val Asp Ala He Gly Glu Xaa His Glu Pro Leu 20 25 (2) INFORMATION FOR SEQ ID NO : 7 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N- terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 7 : Val He Arg Glu Leu His Trp His Arg Glu Ala Gly 1 5 10 (2) INFORMATION FOR SEQ ID NO : 8 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N-terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: Arg Leu Asp Glu Gly Val He Arg Glu Leu His Cys His Arg Glu Ala 1 5 10 15 Glu (2) INFORMATION FOR SEQ ID NO : 9 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N- terminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9 : Ser Tyr Phe Lys Arg Gly Arg Ala Arg Tyr Thr He Phe Ala Ala Glu 1 5 10 15 Gly Asn Ala Arg 20 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (v) FRAGMENT TYPE: N- erminal (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: Ser Ala His Thr Pro Pro Ser Val Leu Ala Gly Asn 1 5 10 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 11 : CAUCAUCAUC AUCCATGGGA YCAYCGNGAY CCYTA 35 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 12 : CUACUACUAC UAAGGCCTGT GNRRYTCNCG DATVA 35 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 13 : CACCATGGTA CGATCACAAG GT 22 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 14 : TCAACGTGAC CGTTCCGGAC T 21 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 440 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: Coding Sequence (B) LOCATION: 4...198 (D) OTHER INFORMATION: (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: ACG ATC ACA AGG TGG ATG CGA TCG GGG AAG GCC ATG AGC CCT TGC CCT 48 He Thr Arg Trp Met Arg Ser Gly Lys Ala Met Ser Pro Cys Pro 1 5 10 15 GGC GCA TGG GAG ATG GAG CCA CCA TCA TGG GAC CCC GCA ACA AGG ACC 96 Gly Ala Trp Glu Met Glu Pro Pro Ser Trp Asp Pro Ala Thr Arg Thr 20 25 30 GTG AGC GCC AGA ACC CCG ACA TGC TCC GTC CTC CGA GCA CCG ACC ATG 144 Val Ser Ala Arg Thr Pro Thr Cys Ser Val Leu Arg Ala Pro Thr Met 35 40 45 GCA ACA TGC CGA ACA TGC GGT GGA GCT TTG CTG ACT CCC ACA TTC GCA 192 Ala Thr Cys Arg Thr Cys Gly Gly Ala Leu Leu Thr Pro Thr Phe Ala 50 55 60 TCG AGG TAAGCCCTTC GAGGGTTTTG TGTACGACAA GCAAAATAGG CTAATGCACT GC 250 Ser Arg 65 AGGAGGGCGG CTGGACACGC CAGACTACCG TACGCGAGCT GCCAACGAGC AAGGAGCTTG 310 CGGGTGTAAA CATGCGCCTC GATGAGGGTG TCATCCGCGA GTTGCACTGG CAAGGGCTGA 370 AGGCGAATTC CAGCACACTG GCGGCCGTTA CTAGTGGATC CGAGCTCGGT ACCAAGCTTG 430 ATGCATAGCT 440 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 65 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (v) FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: He Thr Arg Trp Met Arg Ser Gly Lys Ala Met Ser Pro Cys Pro Gly 1 5 10 15 Ala Trp Glu Met Glu Pro Pro Ser Trp Asp Pro Ala Thr Arg Thr Val 20 25 30 Ser Ala Arg Thr Pro Thr Cys Ser Val Leu Arg Ala Pro Thr Met Ala 35 40 45 Thr Cys Arg Thr Cys Gly Gly Ala Leu Leu Thr Pro Thr Phe Ala Ser 50 55 60 Arg 65 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: AACATGCGGT GGAGCTTTG 19 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CAUCAUCAUC AUCATTCGCA TCGAGGTAAG 30 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: CGCGGATCCG TTTTTTTTTT TTTTTTTV „ 28 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: TAAGGATCCT GGGGGGGGGG GGGH 24 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS .- (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: CAUCAUCAUC AUTACCTCGA TGCGAATGTG 30 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: CGATGATATC AGCAAAATAC ACGCGTAG ,, 28 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: GTCAGGATCC CGCTTCATCC CCATCC 26 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: CATGATATCC TACTCACTTG GGCTCCG 27 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 38 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: GATGACGCAC AATCCCACTA TCCTTCGCAA GACCCTTC 38 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 56 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: GGTTTCGCGA TGATCTGGGG TGAAAGGCTT ATCCTGGGTA GCCAAAACAG CTGGAG 56 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 507 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: GCAGCTTATT TTTACAACAA TTACCAACAA CAACAAACAA AAACAACATT ACAATTACTA 60 TTTACAATTA CAGTCGACCC GGGATCCATG GGTTACTCAA AGACCTTGGT TGCTGGTTTG 120 TTCGCTATGT TGTTGTTGGC TCCAGCTGTT TTGGCTACCC AGGATAAGCC TTTCACCCCA 180 GATCATCGCG ACCCCTATGA TCACAAGGTG GATGCGATCG GGGAAGGCCA TGAGCCCTTG 240 CCCTGGCGCA TGGGAGATGG AGCCACCATC ATGGGACCCC GCAACAAGGA CCGTGAGCGC 300 CAGAACCCCG ACATGCTCCG TCCTCCGAGC ACCGACCATG GCAACATGCC GAACATGCGG 360 TGGAGCTTTG CTGACTCCCA CATTCGCATC GAGGAGGGCG GCTGGACACG CCAGACTACC 420 GTACGCGAGC TGCCAACGAG CAAGGAGCTT GCGGGTGTAA ACATGCGCCT CGATGAGGGT 480 GTCATCCGCG AGTTGCACTG GCATCGA 507 (2) INFORMATION FOR SEQ ID NO: 28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 72 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28: ATGGGTTACT CAAAGACCTT GGTTGCTGGT TTGTTCGCTA TGTTGTTGTT GGCTCCAGCT 60 GTTTTGGCTA CC 72 (2) INFORMATION FOR SEQ ID NO: 29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 34 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: Gly Trp Thr Arg Gin Thr Thr Val Arg Glu Leu Pro Thr Ser Lys Glu 1 5 10 15 Leu Ala Gly Val Asn Met Arg Leu Asp Glu Gly Val He Arg Glu Leu 20 25 30 His Trp

Claims: We Claim: 1. An isolated nucleic acid sequence encoding Aspergillus phoenices oxalate decarboxylase. 2. The nucleic acid sequence of claim 1, having the sequence of the Aspergillus phoenices insert of the plasmid ATCC No. . 3. An isolated nucleic acid sequence encoding an oxalate decarboxylase enzyme from Aspergillus phoenices and comprising at least the coding sequence of SEQ. ID NO: 1 or variations thereof permitted by the degeneracy of the genetic code. 4. The nucleic acid sequence of claim 3, further comprising a plant signal sequence. 5. A vector for delivery of a nucleic acid sequence to a host cell, the vector comprising the nucleic acid sequence of claim 3. 6. A host cell containing the vector of claim 5. 7. A host cell transformed with the nucleic acid sequence of claim 3. 8. The host cell of claim 7, wherein the cell is a plant cell . 9. The host cell of claim 8, wherein the nucleic acid sequence further comprises a plant signal sequence. 10. The host cell of claim 9, wherein said plant signal sequence comprises the Germin signal sequence contained in SEQ ID NO:28. 11. The host cell of claim 8, wherein the plant is selected from the group consisting of sunflower, bean, canola, alfalfa, soybean, flax, safflower, peanut and clover. 12. A plant cell transformed with a nucleic acid sequence comprising at least the coding sequence of SEQ ID NO: 1 or variations thereof permitted by the degeneracy of the genetic code. 13. A plant having stably incorporated within its genome a nucleic acid sequence comprising at least the coding sequence of SEQ ID NO: l or variations thereof permitted by the degeneracy of the genetic code. 14. The plant of claim 13, wherein said nucleic acid sequence further comprises a plant signal sequence. 15. The plant of claim 14, wherein said plant signal sequence comprises the Germin signal sequence contained in SEQ ID NO: 28. 16. A method for degrading oxalic acid comprising expressing in a plant an Aspergillus phoenices oxalic acid decarboxylase from a nucleic acid sequence comprising at least the coding sequence of SEQ ID NO:l or variations thereof permitted by the degeneracy of the genetic code. 17. The method of claim 16, wherein said nucleic acid sequence is integrated into the plant's genome. 18. The method of claim 16, wherein said nucleic acid sequence further comprises a plant signal sequence. 19. The method of claim 18, wherein said plant signal sequence comprises the Germin signal sequence contained in SEQ ED NO: 28. 20. The method of claim 16, wherein said plant is selected from the group consisting of sunflower, bean, canola, alfalfa, soybean, flax, safflower, peanut and clove. 21. The method of claim 20, wherein said plant is sunflower. 22. A method of identifying transformed plant cells using the toxin oxalic acid as a phytotoxic marker, comprising the steps of: culturing cells or tissues from a selected target plant in a culture medium; introducing into cells of the culture at least one copy of an expression cassette comprising a coding sequence of SEQ ID NO: 1 operatively linked to an upstream transcription initiation sequence and a downstream polyadenylation sequence causing expression of the enzyme in the cells; introducing oxalic acid into the culture medium; and identifying transformed cells as the surviving cells in the oxalic acid-treated culture.

Inventors: BIDNEY DENNIS L, SCELONGE CHRISTOPHER J, BIDNEY, DENNIS, L., SCELONGE, CHRISTOPHER, J.
Applicants: BIDNEY DENNIS L, PIONEER HI BRED INT, SCELONGE CHRISTOPHER J, BIDNEY, DENNIS, L., PIONEER HI-BRED INTERNATIONAL, INC., SCELONGE, CHRISTOPHER, J.
Application year: 1998
Main classification: C12N9
IPC codes: C12N9, C12N15